Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Pain
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Pain
    TopAbstracts in Pain 07/02/2009 - (DGNews)
    FDA Panel Recommends Withdrawal of Acetaminophen-Containing Narcotics - (DGNews)
    Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study - (BMJ)
    TopAbstracts in Pain 06/25/2009 - (DGNews)
    EMEA Recommends Withdrawal of Dextropropoxyphene-Containing Medicines - (DGNews)

    News archive

     Recent webcasts/CME - Pain
    A Guide to Advances in Pain Management: A Synopsis of Roundtable Discussions
    Herpes Zoster (Shingles) and Postherpetic Neuralgia Management

    Webcasts/CME archive

     Recent cases - Pain
      Acute Abdominal Pain in a Patient Receiving Enoxaparin
      Rare Case of Autonomic Instability of the Lower Limb Presenting as Painless Complex Regional Pain Syndrome Type I Following Hip Surgery: Two Case Reports
      Non-Invasive Neurosensory Testing Used to Diagnose and Confirm Successful Surgical Management of Lower Extremity Deep Distal Posterior Compartment Syndrome
      Treatment Resistant Trigeminal Neuralgia Relieved with Oral Sumatriptan: A Case Report
      Femoral Nerve Compression Secondary to a Ganglion Cyst Arising from a Hip Joint: A Case Report and Review of the Literature

      Cases archive
        




      my personal edition > pain > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Duloxetine May Alleviate Both Pain and General Anxiety Disorder: Presented at AAPM

      By Jerry Ingram

      NEW ORLEANS, LA -- February 12, 2007 -- Duloxetine appears to offer pain relief for patients with both general anxiety disorder (GAD) and painful physical symptoms, according to research presented here at the American Academy of Pain Medicine 23rd Annual Meeting (AAPM).

      "We wanted to look at patients with general anxiety disorder as well as pain. What we found is that patients presenting with anxiety also presented with pain," explained study author Andrea Collier-Johnson, PharmD, medical liaison, Eli Lilly, Indianapolis, Indiana.

      For this investigation researchers pooled and analyzed data from 2 randomized, double-blind studies. In the first study, clinicians assigned 168 patients to duloxetine 60 mg per day, 170 patients to duloxetine 120 mg per day, and 175 to placebo. They carried out the study for 9 weeks.

      The second study was a 10-week investigation that included a flexible-dose approach with patients in the duloxetine group (n = 168) receiving between 60 and 120 mg per day and 159 patients in the placebo group.

      The Hamilton Anxiety Scale (HAMA), the Visual Analogue Scales (VAS) for pain and the Sheehan Disability Scale (SDS) were used as primary and secondary measures of efficacy.

      Results show that patients in the duloxetine group reported significantly greater improvements in anxiety symptoms (HAMA total score) compared with patients receiving placebo (P = .017), and on patient functioning as determined with the SDS (P < .001).

      Patients also experienced improvement in function in the areas of work and school (P = .001), social life (P < .001), and management of family and home life (P < .001).

      Patients in the duloxetine group also experienced significantly greater improvements compared with placebo-treated patients on 5 of 6 VAS pain items, the researchers reported.

      "Overall, we concluded from these 2 studies that patients with generalized anxiety disorder treated with duloxetine did very well, improving their lives as well as decreasing their level of pain," Dr. Collier-Johnson concluded.


      [Presentation title: Efficacy of Duloxetine in the Treatment of Generalized Anxiety Disorder in Patients With Clinically Significant Painful Physical Symptoms. Poster 112]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send